IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD)

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / Class A Common Stock
Shares outstanding
161,976,581
Total 13F shares
131,861,633
Share change
+18,047,894
Total reported value
$1,624,155,433
Put/Call ratio
67%
Price per share
$12.32
Number of holders
136
Value change
+$222,834,823
Number of buys
78
Number of sells
45

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q1 2014

As of 31 Mar 2014, IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by 136 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 131,861,633 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT CO LLP, BVF INC/IL, MORGAN STANLEY, VANGUARD GROUP INC, DEUTSCHE BANK AG\, STATE OF WISCONSIN INVESTMENT BOARD, JANUS CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, and BlackRock Fund Advisors. This page lists 135 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.